ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
6 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
930
|
197K
|
6
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
1 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
930
|
197K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
4 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
930
|
197K
|
4
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
1 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
930
|
197K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
IDT written submission to The Government
|
|
Frothman
|
3 |
1.0K |
4 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
3
|
1.0K
|
4
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
5 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
930
|
197K
|
5
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
8 |
10/04/21 |
10/04/21 |
ASX - By Stock
|
930
|
197K
|
8
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
3 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
930
|
197K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
0 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
930
|
197K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID19 Vaccine Feasibility Assessment
|
|
Frothman
|
930 |
197K |
6 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
930
|
197K
|
6
|
|
ASX - By Stock
|
AIM |
Re:
Ann: Change of Director's Interest Notice - Appendix 3Y - D Weir
|
|
Frothman
|
9 |
2.0K |
0 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
9
|
2.0K
|
0
|
|
ASX - By Stock
|
AIM |
Re:
Ann: Change of Director's Interest Notice - Appendix 3Y - D Weir
|
|
Frothman
|
9 |
2.0K |
0 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
9
|
2.0K
|
0
|
|
ASX - By Stock
|
ALC |
Re:
Sept. Qtr cashflow report
|
|
Frothman
|
17 |
7.5K |
5 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
17
|
7.5K
|
5
|
|
ASX - By Stock
|
AIM |
Re:
Ann: Change of Director's Interest Notice - Appendix 3Y - D Weir
|
|
Frothman
|
9 |
2.0K |
1 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
9
|
2.0K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Unannounced contract?
|
|
Frothman
|
7 |
2.2K |
1 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
7
|
2.2K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Unannounced contract?
|
|
Frothman
|
7 |
2.2K |
1 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
7
|
2.2K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Unannounced contract?
|
|
Frothman
|
7 |
2.2K |
1 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
7
|
2.2K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Unannounced contract?
|
|
Frothman
|
7 |
2.2K |
0 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
7
|
2.2K
|
0
|
|
ASX - By Stock
|
ALC |
Re:
Sept. Qtr cashflow report
|
|
Frothman
|
17 |
7.5K |
3 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
17
|
7.5K
|
3
|
|
ASX - By Stock
|
AIM |
Re:
Ann: Becoming a substantial holder
|
|
Frothman
|
4 |
1.9K |
1 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
4
|
1.9K
|
1
|
|
ASX - By Stock
|
BOL |
Re:
BOL - Always underperforming
|
|
Frothman
|
10 |
4.7K |
1 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
10
|
4.7K
|
1
|
|
ASX - By Stock
|
AIM |
Re:
Ann: Corporate Governance Statement
|
|
Frothman
|
12 |
3.0K |
0 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
12
|
3.0K
|
0
|
|
ASX - By Stock
|
AIM |
Re:
Ann: Corporate Governance Statement
|
|
Frothman
|
12 |
3.0K |
0 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
12
|
3.0K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Two Victorian Companies for Covid-19 Vaccine Manufacture
|
|
Frothman
|
8 |
2.5K |
1 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
8
|
2.5K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
Two Victorian Companies for Covid-19 Vaccine Manufacture
|
|
Frothman
|
8 |
2.5K |
1 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
8
|
2.5K
|
1
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Change of Director's Interest Notice
|
|
Frothman
|
36 |
12K |
4 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
36
|
12K
|
4
|
|
ASX - By Stock
|
AIM |
Re:
Ann: Presentation Bell Potter Emerging Leaders Conference 17 Sep
|
|
Frothman
|
15 |
5.0K |
2 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
15
|
5.0K
|
2
|
|
ASX - By Stock
|
HCL |
Re:
Ann: Presentation to ASX Small and Mid-Cap Conference
|
|
Frothman
|
14 |
4.2K |
1 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
14
|
4.2K
|
1
|
|
ASX - By Stock
|
HCL |
Re:
Ann: Presentation to ASX Small and Mid-Cap Conference
|
|
Frothman
|
14 |
4.2K |
0 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
14
|
4.2K
|
0
|
|
ASX - By Stock
|
HCL |
Re:
Ann: Presentation to ASX Small and Mid-Cap Conference
|
|
Frothman
|
14 |
4.2K |
0 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
14
|
4.2K
|
0
|
|
ASX - By Stock
|
HCL |
Re:
Tenders
|
|
Frothman
|
152 |
66K |
0 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
152
|
66K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
13/09/20 |
13/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
1 |
13/09/20 |
13/09/20 |
ASX - By Stock
|
27
|
5.5K
|
1
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
12/09/20 |
12/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
BOL - Always underperforming
|
|
Frothman
|
10 |
4.7K |
1 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
10
|
4.7K
|
1
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
BOL - Always underperforming
|
|
Frothman
|
10 |
4.7K |
1 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
10
|
4.7K
|
1
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Two Victorian Companies for Covid-19 Vaccine Manufacture
|
|
Frothman
|
8 |
2.5K |
2 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
8
|
2.5K
|
2
|
|
ASX - By Stock
|
IDT |
Re:
Two Victorian Companies for Covid-19 Vaccine Manufacture
|
|
Frothman
|
8 |
2.5K |
1 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
8
|
2.5K
|
1
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
HCL |
Re:
Ann: Change of Director's Interest Notice for Uwe Boettcher
|
|
Frothman
|
1 |
647 |
0 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
1
|
647
|
0
|
|
ASX - By Stock
|
ALC |
Re:
chart & chat
|
|
Frothman
|
2.2K |
4.1M |
12 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
2.2K
|
4.1M
|
12
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|
ASX - By Stock
|
BOL |
Re:
Ann: Full Year Results Investor Presentation
|
|
Frothman
|
27 |
5.5K |
0 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
27
|
5.5K
|
0
|
|